Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Can low disease activity be achieved with a modern treatment approach in pregnant women with rheumatoid arthritis?

Can low disease activity be achieved with a modern treatment approach in pregnant women with rheumatoid arthritis?

Posted by on Apr 10, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated whether a modern treatment approach is suitable in patients with rheumatoid arthritis (RA) that were pregnant or intended to become pregnant. The authors concluded that low disease activity (LDA) and remission are possible with a modern approach in these women. Some background RA is an inflammatory disease....

Read More

Does smoking impact seropositivity levels in patients with rheumatoid arthritis?

Does smoking impact seropositivity levels in patients with rheumatoid arthritis?

Posted by on Apr 4, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the link between smoking and seropositivity levels of specific autoantibodies in patients with rheumatoid arthritis (RA). The authors concluded that patients with RA who were current smokers had significantly higher seropositivity levels than those that never smoked. Some background Smoking is an environmental risk...

Read More

Can radiographic erosion and joint space narrowing be predicted in early rheumatoid arthritis?

Can radiographic erosion and joint space narrowing be predicted in early rheumatoid arthritis?

Posted by on Mar 31, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated potential predictors of erosions and joint space narrowing (JSN) in patients with early rheumatoid arthritis (RA). The data showed that less JSN progression was seen in postmenopausal, overweight women with RA, and smoking was associated with JSN progression. Some background RA is an autoimmune disease that is...

Read More

Does methotrexate use increase the risk of liver fibrosis in patients with rheumatoid arthritis?

Does methotrexate use increase the risk of liver fibrosis in patients with rheumatoid arthritis?

Posted by on Mar 28, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated whether methotrexate use increased the presence of liver fibrosis (scarring) in patients with rheumatoid arthritis (RA). The data showed that there was no increase in the rate of liver fibrosis in patients with RA that received methotrexate. Some background RA is an inflammatory disease that affects the joints....

Read More

Baricitinib may effectively slow down progression of joint damage in patients with RA

Baricitinib may effectively slow down progression of joint damage in patients with RA

Posted by on Feb 13, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed the effectiveness of baricitinib (Olumiant) on the progression of structural joint damage (SJD) in patients with rheumatoid arthritis (RA). The data showed that baricitinib may significantly help slow down SJD signs found in digital imaging in patients with non-existent or insufficient...

Read More

Interleukin-6 levels predict greater improvement of quality of life with sarilumab than with adalimumab in patients with RA

Interleukin-6 levels predict greater improvement of quality of life with sarilumab than with adalimumab in patients with RA

Posted by on Feb 7, 2021 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the effect of sarilumab (Kevzara) compared to adalimumab (Humira) on health-related quality of life (HRQoL) based on inflammatory marker levels in patients with rheumatoid arthritis (RA).  The data showed that sarilumab has a higher effect on improving aspects of HRQoL in patients...

Read More

Switching between upadacitinib and adalimumab offers benefits in patients with unresponsive rheumatoid arthritis.

Switching between upadacitinib and adalimumab offers benefits in patients with unresponsive rheumatoid arthritis.

Posted by on Dec 20, 2020 in Rheumatoid Arthritis | 0 comments

In a nutshell This trial was carried out to examine the effectiveness of switching from upadacitinib (UPA; Rinvoq) to adalimumab (ADA; Humira) and from ADA to UPA following insufficient response in patients with rheumatoid arthritis (RA). The authors found that patients who do not respond to UPA or ADA can be...

Read More

Does rheumatoid arthritis treatment affect the risk of cardiovascular disease?

Does rheumatoid arthritis treatment affect the risk of cardiovascular disease?

Posted by on Dec 18, 2020 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the effect of disease-modifying anti-rheumatic drugs (DMARDs) on cardiovascular disease (CVD) risk. They found that abatacept (Orencia) and tumor necrosis factor inhibitors (TNFi) were associated with decreased CVD risk. Some background Rheumatoid arthritis (RA) is a chronic condition. It is caused by...

Read More

What is the risk of infection with biological and targeted therapeutics in rheumatoid arthritis?

What is the risk of infection with biological and targeted therapeutics in rheumatoid arthritis?

Posted by on Dec 13, 2020 in Rheumatoid Arthritis | 0 comments

In a nutshell This study reviewed infection risk in patients treated with biologic and targeted disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA). Some background Rheumatoid arthritis (RA) is a chronic condition. It is caused by painful inflammation in the joints. RA is treated with drugs to reduce...

Read More